---
title: "Wedbush Sticks to Their Buy Rating for Immunome (IMNM)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295680062.md"
description: "Wedbush analyst maintained a Buy rating on Immunome today and set a price target of $35.00.Claim 55% Off TipRanks Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks Currently, the analyst consensus on Immunome is a Strong Buy with an average price target of $36.00."
datetime: "2026-08-12T14:05:43.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295680062.md)
  - [en](https://longbridge.com/en/news/295680062.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295680062.md)
generator: "portal-rs"
---

# Wedbush Sticks to Their Buy Rating for Immunome (IMNM)

Wedbush analyst maintained a Buy rating on Immunome today and set a price target of $35.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Currently, the analyst consensus on Immunome is a Strong Buy with an average price target of $36.00.

### Related Stocks

- [IMNM.US](https://longbridge.com/en/quote/IMNM.US.md)

## Related News & Research

- [Immunome (IMNM) Starts IM 3050 Trial As Valuation Questions Come Into View](https://longbridge.com/en/news/295500222.md)
- [Immunome (NASDAQ:IMNM) Insider Robert Lechleider Sells 55,000 Shares](https://longbridge.com/en/news/292044247.md)
- [Freeport-McMoRan (FCX): New Buy Recommendation for This Basic Materials Giant](https://longbridge.com/en/news/296794439.md)
- [Alliance Global Partners Reaffirms Their Buy Rating on Pelthos Therapeutics (PTHS)](https://longbridge.com/en/news/296781912.md)
- [Scotiabank Sticks to Its Buy Rating for Movida Participacoes SA (MOVI3)](https://longbridge.com/en/news/296795664.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**